Xiamen Amoytop (China) Today
| 688278 Stock | 73.37 0.03 0.04% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Xiamen Amoytop is trading at 73.37 as of the 2nd of January 2025, a 0.04 percent decrease since the beginning of the trading day. The stock's open price was 73.4. Xiamen Amoytop has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 13th of January 2023 and ending today, the 2nd of January 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Xiamen Amoytop is entity of China. It is traded as Stock on SHG exchange. The company has 406.8 M outstanding shares. More on Xiamen Amoytop Biotech
Moving against Xiamen Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Xiamen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Xiamen Amoytop's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Xiamen Amoytop or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman GM | Li Sun |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Xiamen Amoytop Biotech (688278) is traded on Shanghai Stock Exchange in China and employs 1,960 people. Xiamen Amoytop is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 29.96 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Xiamen Amoytop's market, we take the total number of its shares issued and multiply it by Xiamen Amoytop's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Xiamen Amoytop Biotech operates under Biotechnology sector and is part of Health Care industry. The entity has 406.8 M outstanding shares.
Xiamen Amoytop generates positive cash flow from operations, but has no cash available
Check Xiamen Amoytop Probability Of Bankruptcy
Ownership AllocationXiamen Amoytop Biotech retains a total of 406.8 Million outstanding shares. Xiamen Amoytop Biotech maintains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 67.08 (%) of Xiamen Amoytop Biotech outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Xiamen Ownership Details
Xiamen Amoytop Biotech Risk Profiles
Although Xiamen Amoytop's alpha and beta are two of the key measurements used to evaluate Xiamen Amoytop's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.34 | |||
| Semi Deviation | 2.17 | |||
| Standard Deviation | 3.54 | |||
| Variance | 12.5 |
Xiamen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Xiamen Amoytop without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Xiamen Amoytop Corporate Management
Elected by the shareholders, the Xiamen Amoytop's board of directors comprises two types of representatives: Xiamen Amoytop inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Xiamen. The board's role is to monitor Xiamen Amoytop's management team and ensure that shareholders' interests are well served. Xiamen Amoytop's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Xiamen Amoytop's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Weidong Zhou | Deputy Manager | Profile | |
| Meihua Yang | Deputy Technician | Profile | |
| Shiyuan Wang | Technical Center | Profile | |
| Linzhong Zhang | Deputy Manager | Profile | |
| Fanghe Chen | Deputy Manager | Profile |
Other Information on Investing in Xiamen Stock
Xiamen Amoytop financial ratios help investors to determine whether Xiamen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Xiamen with respect to the benefits of owning Xiamen Amoytop security.